Heska Corp
HSKADelisted Jun 13, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001038133
Heska Corp was delisted on Jun 13, 2023; its insiders filed their last Form 4 on Jun 14, 2023; 152 institutions reported holding it in 13F filings for Q1 2023, worth $1.01B in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Heska Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 4 | 0 | −4 |
| Shares | 11.2K | 0 | −11.2K (−100.0%) |
| Value | $1.14M | $0 | −$1.14M (−100.0%) |
New holders (0)
Institutions that held Heska Corp at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (4)
Institutions that held Heska Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| UBS Asset Management Americas Inc | 9,241 | $902.1K |
| Everence Capital Management Inc | 1,950 | $233.0K |
| FinTrust Capital Advisors, LLC | 23 | $1.43K |
| Ronald Blue Trust, Inc. | 7 | $1.00K |